Type 2 Diabetes Trial, Recruiting NCT06185296 Sponsor: Aalborg University Hospital Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06185296
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older.
  • People who have been diagnosed with type 2 diabetes for at least 12 months before the screening date.
  • People who are currently using insulin or are about to start insulin treatment for the first time, and who are willing to travel to the trial site in North Denmark for in-person visits.
  • People who have internet access at home, have a MitID (Danish digital ID), and are willing to use a smartphone and other devices required by the trial.
  • People who have signed a consent form agreeing to take part in the trial.
  • People who are able to understand and read Danish.

Who may not be able to join:

  • People who are pregnant or breastfeeding.
  • People who have major surgery planned during the trial period.
  • People who have been diagnosed with cancer within the five years before joining the trial.
  • People who are currently taking part in another clinical trial that involves a treatment or intervention.
  • People whose reading or writing ability may make it difficult to use the trial devices.
  • People who have worn a continuous glucose monitor (a device that tracks blood sugar levels) within the six months before the trial.
  • People who, in the opinion of the trial doctors, are considered unsuitable to participate for any reason, including difficulty understanding the trial or limited physical or mental ability to take part.
  • People whose insulin treatment uses a pre-mixed type of insulin.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Vestergaard, MD, PhD, Steno Diabetes Center North Denmark

Phone: 004523676513

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aalborg University Hospital
Registry
ClinicalTrials.gov
Start date
15 November 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

CGM time in range

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov